C

Capstan Medical

Catheter-based heart valve replacement via robotics

Senior Clinical Development Engineer

Biomedical Engineering & Medical DevicesPosted on Nov 12
Full-timeSanta Cruz, CA, USANo salary listedIn-person

About the Job

Requirements

  • Bachelor’s degree in Biomedical Engineering, Mechanical Engineering, or a related field.
  • Proficiency in DICOM analysis software.

Responsibilities

  • Collaborate with cross-functional teams to design, test, and refine medical robotics systems for transcatheter structural heart procedures.
  • Conduct pre-clinical evaluations and assessments to validate the safety, efficacy, and performance of Capstan Medical’s technology.
  • Collaborate with clinical field team to model Support clinical trials by implementing and monitoring data collection processes, ensuring compliance with regulatory requirements and ethical standards.
  • Analyze and interpret clinical data to identify trends, insights, and potential areas for improvement.
  • Collaborate with physicians, surgeons, and other healthcare professionals to gather feedback and insights for product refinement.
  • Stay up-to-date with the latest advancements and best practices in medical robotics and transcatheter structural heart procedures, and apply this knowledge to enhance Capstan Medical’s technology.
  • Assist in the preparation of technical documentation, including reports, publications, and presentations.

Desired Qualifications

  • 5+ years of experience in the medical device industry, particularly in clinical development, is highly desirable.
  • Knowledge of regulatory requirements, including FDA guidelines for medical device development, is a plus.

About the Company

Capstan Medical

Catheter-based heart valve replacement via robotics

Capstan Medical develops catheter-based heart valve replacement tools that use surgical robotics to guide valve implants through blood vessels, avoiding open-heart surgery. Its system combines implants, delivery catheters, and robotic navigation to treat mitral and tricuspid valve disease with minimally invasive techniques. It differentiates itself by integrating robotic guidance with catheter delivery to perform valve replacements without large incisions, aiming for safer, quicker recoveries. Its goal is to provide less invasive, effective treatments for structural heart disease.

Company size
51-200
Company stage
Series C
Total funding
$141.4M
Headquarters
Santa Cruz, CA
Founded
2020

Recently Posted Jobs

Explore more opportunities at Capstan Medical

See more jobs